Zurich Insurance Group Ltd : Is the distribution phase coming to an end ?
Entry price | Target | Stop-loss | Potential |
---|
CHF 459 |
CHF 475 |
CHF 445 |
+3.49% |
---|
Zurich Insurance Group Ltd shares stand out with an interesting technical chart pattern displaying horizontal consolidation. One would assume that the current accumulation phase will cede eventually to an acceleration to the upside.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths● The company is one of the best yield companies with high dividend expectations.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● In relation to the value of its tangible assets, the company's valuation appears relatively high.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.